key: cord-0914451-p8oicbhe authors: Redshaw, Natalie; Wood, Catherine; Rich, Fenella; Grimwood, Keith; Kirman, Joanna R. title: Human Bocavirus in Infants, New Zealand date: 2007-11-03 journal: Emerg Infect Dis DOI: 10.3201/eid1311.070793 sha: 7e78314c36ae7c4c1c8caa99dd9d562d0c08f40f doc_id: 914451 cord_uid: p8oicbhe nan To the Editor: In 2005, a parvovirus, subsequently named human bocavirus (HBoV), was discovered in respiratory samples taken from infants and children hospitalized at Karolinksa University Hospital, Sweden, with lower respiratory tract infection (1) . HBoV has since been identifi ed in infants and children with respiratory illness in >17 countries, at frequencies ranging from 1.5% to >18.0%. In the past decade New Zealand has experienced increasing bronchiolitis hospitalization rates, currently >70 admissions per 1,000 infants. To determine the contribution of HBoV to New Zealand's bronchiolitis disease prevalence, we tested samples collected from infants hospitalized with community-acquired bronchiolitis (2) during 3 consecutive winter epidemics (June to October, 2003; July to October, 2004; and June to October, 2005) in Wellington, NZ, for HBoV by PCR. The Central Regional Ethics Committee approved the study. Written, informed consent was obtained from the parent or guardian. Demographic, clinical, and laboratory data were collected during hospitalization. Ethnicity of those who ascribe to >1 group was determined by using a national census method that prioritizes ethnicity as follows: Māori>Pacifi c>Other>New Zealand European. Oxygen requirement was determined to be the best measure of bronchiolitis severity (2) . Infants who needed assisted ventilation or continuous positive airway pressure were classifi ed severe; those who required oxygen supplementation moderate; and infants who were hospitalized but did not require supplemental oxygen mild. Nucleic acid was extracted from thawed nasopharyngeal aspirates (stored at 80°C) by using a High Pure Viral Nucleic Acid kit (Roche Diagnostics, Auckland, NZ). The HBoV nonstructural protein (NP-1) gene was amplifi ed by using primers 188F (5′-GAGCTCTGTAAGTACTATTAC-3′) and 542R (5′-CTCTGTGTTGACT-GAATACAG-3′) (1) with Expand High Fidelity DNA Polymerase (Roche Diagnostics, Basel, Switzerland) for 35 cycles. Products (354 bp) were purifi ed and sequenced from primers 188F and 542R on an ABI3730 Genetic Analyzer by using a BigDye Terminator version 3.1 Ready Reaction Cycle Sequencing kit (Applied Biosystems, Foster City, CA, USA). Sequences were submitted to GenBank under accession nos. EF686006-13. Alignments of NP-1 gene sequences from nucleotides (nt) 2410-2602, and NP-1 predicted amino acid sequences from amino acids (aa) 1-97 were constructed by using ClustalW version 1.83 (available from www. ebi.ac.uk/tools/clustalw/index.html) and compared with HBoV prototype sequences from GenBank (DQ00495-6). Nasopharyngeal aspirates were also screened for respiratory syncytial virus (RSV) by reverse transcription-PCR (RT-PCR) and nested PCR (3) and for human metapneumovirus (4), infl uenza A (H1, H3), and infl uenza B by RT-PCR (5). Eight (3.5%) of 230 samples, collected from infants hospitalized with bronchiolitis during the 2003-2005 winter epidemic seasons, were positive for HBoV. In 5 HBoV-positive infants no other pathogens were identifi ed, but RSV was detected in 3 (Table) . The 8 HBoV-positive infants had a median age of 9.5 months, and the male:female ratio was 1:1. The median length of hospital stay was 5.5 (range 1-16) days. As expected, because HBoV NP-1 is highly conserved, sequence variation among New Zealand isolates and the prototype Stockholm ST-1 and ST-2 (1) NP-1 sequences was limited. Alignments of the partial NP-1 sequence (nt 2410-2602) of New Zea- Letters commenting on recent articles as well as letters reporting cases, outbreaks, or original research are welcome. Letters commenting on articles should contain no more than 300 words and 5 references; they are more likely to be published if submitted within 4 weeks of the original article's publication. Letters reporting cases, outbreaks, or original research should contain no more than 800 words and 10 references. They may have one Figure or Table and should not be divided into sections. All letters should contain material not previously published and include a word count. land isolates with those of ST-1 and ST-2 were identical, except for a G→ A change at nt 176 in 2 New Zealand isolates (from infants 5 and 8 years of age), which resulted in a predicted amino acid exchange of S→N at aa 59. In addition, an A→T change at nt 274 in all 8 NZ isolates resulted in a predicted amino acid substitution of T→S at aa 92, a change that has been reported previously in Japanese isolates (6) . This study reaffi rms previous reports of fi nding HBoV in a subset of infants with bronchiolitis (7). It is also, to our knowledge, the fi rst study of its kind in New Zealand infants, confi rming wide distribution of HBoV. In the northern hemisphere, HBoV circulates primarily during the winter months, although it continues circulating until early summer, later than most other seasonal respiratory viruses (8) . Therefore, this study may underestimate the percentage of New Zealand infants with bronchiolitis whose HBoV test results were positive because sample collection ceased in October (south-ern hemisphere spring) at the end of the bronchiolitis epidemic. The small number of HBoV-positive infants prevents conclusions concerning ethnicity, coinfection, and bronchiolitis severity. Although detection of viral nucleic acid by PCR in infants with bronchiolitis does not prove that the virus is the cause of the disease, it raises a hypothesis worthy of investigation. Further studies are required to determine the role of HBoV as a human pathogen. Although coinfection is common, HBoV detection appears to be infrequent in asymptomatic controls (9) . In our study RSV was detected in 3 (37.5%) HBoV-positive samples. We may have underestimated additional coinfection because we did not test for several respiratory agents, including parainfl uenza viruses, rhinoviruses, or the newly discovered coronaviruses. Finally, HBoV has recently been detected in fecal samples (10) . Because 3 HBoV-positive infants had diarrhea in addition to bronchiolitis, knowing prevalence of HBoV in fecal specimens from asymptomatic New Zealand children and in those with acute gastroenteritis would be of interest. Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 13, No. 11, November 2007 To the Editor: Lyme disease is a multisystem illness caused by infection with the tickborne spirochete Borrelia burgdorferi. Most infections in the United States occur in the Northeast and upper Midwest, and the midwestern focus now includes Illinois (1, 2) . Previously, the greatest risk of contracting Lyme disease in the Midwest was confi ned to the northernmost states (Wisconsin and Minnesota) and did not encroach into heavily populated areas around the city of Chicago. However, we showed recently that B. burgdorferi-infected Ixodes scapularis ticks were recovered from sites in Cook and DuPage counties (3), but the percentages of infected ticks were low (<5%). Since that time, however, reports of Lyme disease in Cook County have been reviewed and individual I. scapularis tick submissions from Lake County, north of Chicago, have been received. We therefore surveyed new areas north of Chicago (closest was <1 mile from the city limits; farthest was ≈25 miles from the city limits) and examined additional ticks for infection with B. burgdorferi. From December 2006 to May 2007, we collected 172 adult I. scapularis ticks from sites to the north and northwest of Chicago (Figure) . Adult ticks were collected because nymphal ticks are more diffi cult to obtain, and the infection rate in adult ticks is similar (1). The tick midguts were removed aseptically, inoculated into tubes containing 1 mL of modifi ed Barbour-Stoenner-Kelly medium (4), incubated at 35ºC, and examined for spirochetes for up to 3 weeks. Spirochetes were recovered from 21 (32%) of 65 ticks and 40 (37%) of 107 ticks collected from sites in Cook and Lake counties, respectively. In addition, PCR using primers specifi c for outer surface protein A (5) confi rmed that the spirochetes were B. burgdorferi. The fi ndings demonstrate that the midwestern endemic focus of Cloning of a human parvovirus by molecular screening of respiratory tract samples Association of fever and severe clinical course in bronchiolitis Distinct patterns of evolution between respiratory syncytial virus subgroups A and B from New Zealand isolates collected over thirty-seven years A 1-year experience with human metapneumovirus in children aged <5 years Typing and subtyping of infl uenza viruses and respiratory syncytial viruses by multiplex RT-PCR Detection of human bocavirus in Japanese children with lower respiratory tract infections Evidence of human coronavirus HKU1 and human bocavirus in Australian children Human bocavirus in children Human bocavirus infection in young children in the United States: molecular epidemiological profi le and clinical characteristics of a newly emerging respiratory virus Human bocavirus, a respiratory and enteric virus We thank Dr Tobias Allander of the Karolinska Institute, Sweden, for providing a plasmid encoding the HBoV (NP-1) gene. We are also grateful to the staff of Ward 19 and the diagnostic laboratories at Wellington Hospital for assistance in obtaining clinical samples.This study was funded by the New Zealand Lottery Health Grants Board, the Child Health Research Foundation of New Zealand, and the Wellington Medical Research Foundation.